Literature DB >> 11042031

Dosage-response in the treatment of Gaucher disease by enzyme replacement therapy.

E Beutler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11042031     DOI： 10.1006/bcmd.2000.0311

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  5 in total

1.  Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing.

Authors:  Raphael Schiffmann; Hasan Askari; Margaret Timmons; Chevalia Robinson; William Benko; Roscoe O Brady; Markus Ries
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

2.  Glycolipid analysis of different tissues and cerebrospinal fluid in type II Gaucher disease.

Authors:  R Gornati; B Berra; G Montorfano; C Martini; G Ciana; P Ferrari; M Romano; B Bembi
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

3.  Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

Authors:  Gregory A Grabowski; Katherine Kacena; J Alexander Cole; Carla E M Hollak; Lin Zhang; John Yee; Pramod K Mistry; Ari Zimran; Joel Charrow; Stephan vom Dahl
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

4.  Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.

Authors:  Deborah Elstein; Ari Zimran
Journal:  Biologics       Date:  2009-09-15

Review 5.  Enzyme replacement in Gaucher disease.

Authors:  Ernest Beutler
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.